Summary
Elevance Health, Inc. (ELV) reported its financial results for the third quarter and the first nine months of fiscal year 2025. The company demonstrated revenue growth driven by premium rate increases and expansion in its Medicare Advantage business, partially offset by Medicaid attrition. Net income saw an increase for the quarter, but a decrease for the nine-month period, influenced by factors such as investment performance, interest expenses, and tax impacts. Total assets grew to $122.8 billion from $116.9 billion at year-end 2024, with increases in current assets like premiums receivables and other receivables. Liabilities also increased, primarily due to higher medical claims payable and long-term debt. The company continues to manage its capital through dividends and share repurchases, while also investing in strategic acquisitions and business optimization initiatives. Regulatory changes and market dynamics, particularly in the healthcare landscape, remain key considerations for future performance.
Financial Highlights
51 data points| Revenue | $50.71B |
| Cost of Revenue | $5.38B |
| Gross Profit | $45.33B |
| SG&A Expenses | $5.27B |
| Operating Income | $1.29B |
| Net Income | $1.19B |
| EPS (Basic) | $5.32 |
| EPS (Diluted) | $5.32 |
| Shares Outstanding (Basic) | 223.30M |
| Shares Outstanding (Diluted) | 223.70M |
Key Highlights
- 1Total operating revenue increased by 12.0% for the three months ended September 30, 2025, to $50.1 billion, and by 13.9% for the nine months ended September 30, 2025, to $148.3 billion, driven by premium rate increases and Medicare Advantage growth.
- 2Shareholders' net income for the third quarter of 2025 rose by 17.0% to $1.19 billion, resulting in diluted EPS of $5.32, up from $4.36 in the prior year quarter.
- 3For the nine-month period, shareholders' net income decreased by 8.0% to $5.12 billion, with diluted EPS at $22.67, down from $23.81 in the prior year.
- 4Medical claims payable increased to $17.1 billion, reflecting higher benefit expenses and an increase in incurred claims.
- 5The company repurchased approximately $2.13 billion of common stock during the nine months ended September 30, 2025, compared to $1.09 billion in the prior year period.
- 6Total medical membership slightly declined by 0.9% to 45.4 million members, primarily due to decreases in BlueCard® business and Medicaid membership attrition, offset by growth in Medicare Advantage.
- 7The company finalized its acquisition of Centers and CareBridge in late 2024, with initial accounting adjustments impacting goodwill and intangible assets.